Plegridy Drug Interactions: 220 Major, 47 Moderate
Plegridy (Peginterferon Beta-1a) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Plegridy. Always confirm against the full prescribing information.
100 interactions
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon beta-1a.
Level 1 evidence
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Peginterferon beta-1a.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon beta-1a.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Peginterferon beta-1a.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Peginterferon beta-1a.
Level 2 evidence
Bromotheophylline
The metabolism of Bromotheophylline can be decreased when combined with Peginterferon beta-1a.
Level 2 evidence
Caffeine
The metabolism of Caffeine can be decreased when combined with Peginterferon beta-1a.
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon beta-1a.
Level 2 evidence
Clozapine
The risk or severity of neutropenia can be increased when Peginterferon beta-1a is combined with Clozapine.
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon beta-1a.
Level 2 evidence
Cyanocobalamin
The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon beta-1a.
Level 1 evidence
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon beta-1a.
Level 1 evidence
Enter your NPI to unlock 63 major interactions for Plegridy
Plegridy (Peginterferon Beta-1a) has 335 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Plegridy (Peginterferon Beta-1a) has 220 major, 47 moderate, and 68 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Plegridy. Always confirm against the full prescribing information.